These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides. Iyengar S; Kim HS; Wood PL Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574 [TBL] [Abstract][Full Text] [Related]
47. Plasma beta-endorphin and natural killer cell activity in major depression: a preliminary study. Darko DF; Irwin MR; Risch SC; Gillin JC Psychiatry Res; 1992 Aug; 43(2):111-9. PubMed ID: 1410068 [TBL] [Abstract][Full Text] [Related]
48. Identification of specific pathways of communication between the CNS and NK cell system. Hiramoto R; Ghanta V; Solvason B; Lorden J; Hsueh CM; Rogers C; Demissie S; Hiramoto N Life Sci; 1993; 53(7):527-40. PubMed ID: 8350666 [TBL] [Abstract][Full Text] [Related]
49. Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages. Ichinose M; Asai M; Sawada M J Neuroimmunol; 1995 Jul; 60(1-2):37-43. PubMed ID: 7642746 [TBL] [Abstract][Full Text] [Related]
50. Release of beta-endorphin immunoreactivity into ventriculo-cisternal perfusate by lumbar intrathecal capsaicin in the rat. Bach FW; Yaksh TL Brain Res; 1995 Dec; 701(1-2):192-200. PubMed ID: 8925284 [TBL] [Abstract][Full Text] [Related]
52. Effect of reserpine on retention of the conditioned NK cell response. Hiramoto R; Solvason B; Ghanta V; Lorden J; Hiramoto N Pharmacol Biochem Behav; 1990 May; 36(1):51-6. PubMed ID: 2349268 [TBL] [Abstract][Full Text] [Related]
53. Opioid activity of beta-endorphin-like proteins from Tetrahymena. Rodriguez E; Lazaro MI; Renaud FL; Marino M J Eukaryot Microbiol; 2004; 51(1):60-5. PubMed ID: 15068266 [TBL] [Abstract][Full Text] [Related]
54. Effects of antibodies to dynorphin A and beta-endorphin on lateral hypothalamic self-stimulation in ad libitum fed and food-deprived rats. Carr KD Brain Res; 1990 Nov; 534(1-2):8-14. PubMed ID: 1981487 [TBL] [Abstract][Full Text] [Related]
55. Effect of dexamethasone on conditioned enhancement of natural killer cell activity. Hsueh CM; Rogers C; Hiramoto RN; Ghanta VK Neuroimmunomodulation; 1994; 1(6):370-6. PubMed ID: 7671125 [TBL] [Abstract][Full Text] [Related]
56. Acquisition of enhanced natural killer cell activity under anesthesia. Hsueh CM; Lorden JF; Hiramoto RN; Ghanta VK Life Sci; 1992; 50(26):2067-74. PubMed ID: 1608290 [TBL] [Abstract][Full Text] [Related]
58. Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice. Suh HH; Tseng LF J Pharmacol Exp Ther; 1988 May; 245(2):587-93. PubMed ID: 2966856 [TBL] [Abstract][Full Text] [Related]
59. [Effect of anti-opioid peptide sera on oxytocin-induced enhancement of electroacupuncture analgesia]. Song CY; Liu WY; Gu XY; Lin BC Sheng Li Xue Bao; 1993 Jun; 45(3):231-6. PubMed ID: 7901915 [TBL] [Abstract][Full Text] [Related]